David G Kent (David Kent)

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 31

Top Venues

HemaSphere

Blood

Nature

Nature communications

University of York

University of British Columbia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of York Sep 01 2019

United Kingdom

Reader :: Biology

University of Cambridge Oct 01 2009 - Jul 31 2015

United Kingdom

Research Associate :: Haematology

Education History

University of British Columbia Sep 01 2003 - Apr 02 2009

Canada

PHD :: Genetics

Western University Sep 01 1999 - Apr 30 2003

Canada

BSC :: Genetics with English Literature

Publications

Alyssa H Cull, David G Kent, Alan John Warren
Emerging genetic technologies informing personalized medicine in Shwachman-Diamond syndrome and other inherited BMF disorders. Blood 144 (9) (2024)
David G Kent
New approaches in gene therapy for sickle cell disease, moving in vivo. HemaSphere 8 (3) (2024)
David G Kent
Next-level multiomics helps define new critical pathways in developmental hematopoiesis. HemaSphere 8 (2) (2024)
David G Kent
Next-level multiomics helps define new critical pathways in developmental hematopoiesis. HemaSphere 8 (2) (2024)
David G Kent
New approaches in gene therapy for sickle cell disease, moving in vivo. HemaSphere 8 (3) (2024)
David G Kent
Battle of the sexes: Understanding donor:recipient sex differences in transplantation biology. HemaSphere 8 (9) (2024)
David G Kent
New approaches in gene therapy for sickle cell disease, moving in vivo. HemaSphere 8 (3) (2024)
David G Kent
Different roles for different bones - Location matters for blood production. HemaSphere 8 (7) (2024)
David G Kent
He shoots, he scores: Navigating the complex world of transcriptomic scores in the age of artificial intelligence. HemaSphere 8 (3) (2024)
Alyssa H Cull, David G Kent, Alan John Warren
Emerging genetic technologies informing personalized medicine in Shwachman-Diamond syndrome and other inherited BMF disorders. Blood 144 (9) (2024)
Alyssa H Cull, David G Kent, Alan John Warren
Emerging genetic technologies informing personalized medicine in SDS and other inherited bone marrow failure disorders. Blood (2024)
David G Kent
Different roles for different bones - Location matters for blood production. HemaSphere 8 (7) (2024)
David G Kent
He shoots, he scores: Navigating the complex world of transcriptomic scores in the age of artificial intelligence. HemaSphere 8 (3) (2024)
Masatoshi Sakurai, Kantaro Ishitsuka, Ryoji Ito, Adam C Wilkinson, Takaharu Kimura, Eiji Mizutani, Hidekazu Nishikii, Kazuhiro Sudo, Hans Jiro Becker, Hiroshi Takemoto, Tsubasa Sano, Keisuke Kataoka, Satoshi Takahashi, Yukio Nakamura, David G Kent, Atsushi Iwama, Shigeru Chiba, Shinichiro Okamoto, Hiromitsu Nakauchi, Satoshi Yamazaki
Chemically defined cytokine-free expansion of human haematopoietic stem cells. Nature 615 (7950) (2023)
Michael Spencer Chapman, Alyssa H Cull, Marioara F Ciuculescu, Erica B Esrick, Emily Mitchell, Hyunchul Jung, Laura O'Neill, Kirsty Roberts, Margarete A Fabre, Nicholas Williams, Jyoti Nangalia, Joanne Quinton, James M Fox, Danilo Pellin, Julie Makani, Myriam Armant, David A Williams, Peter J Campbell, David G Kent
Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease. Nature medicine (2023)
Masatoshi Sakurai, Kantaro Ishitsuka, Ryoji Ito, Adam C Wilkinson, Takaharu Kimura, Eiji Mizutani, Hidekazu Nishikii, Kazuhiro Sudo, Hans Jiro Becker, Hiroshi Takemoto, Tsubasa Sano, Keisuke Kataoka, Satoshi Takahashi, Yukio Nakamura, David G Kent, Atsushi Iwama, Shigeru Chiba, Shinichiro Okamoto, Hiromitsu Nakauchi, Satoshi Yamazaki
Chemically defined cytokine-free expansion of human haematopoietic stem cells. Nature 615 (7950) (2023)
Heather E Machado, Nina F Øbro, Nicholas O Williams, Shengjiang Tan, Ahmed Z Boukerrou, Megan Davies, Miriam Belmonte, Emily Mitchell, E Joanna Baxter, Nicole Mende, Anna Clay, Philip Ancliff, Jutta Köglmeier, Sally B Killick, Austin Kulasekararaj, Stefan Meyer, Elisa Laurenti, Peter J Campbell, David G Kent, Jyoti Nangalia, Alan John Warren
Convergent somatic evolution commences in utero in a germline ribosomopathy. Nature communications 14 (1) (2023)
Masatoshi Sakurai, Kantaro Ishitsuka, Ryoji Ito, Adam C Wilkinson, Takaharu Kimura, Eiji Mizutani, Hidekazu Nishikii, Kazuhiro Sudo, Hans Jiro Becker, Hiroshi Takemoto, Tsubasa Sano, Keisuke Kataoka, Satoshi Takahashi, Yukio Nakamura, David G Kent, Atsushi Iwama, Shigeru Chiba, Shinichiro Okamoto, Hiromitsu Nakauchi, Satoshi Yamazaki
Chemically defined cytokine-free expansion of human haematopoietic stem cells. Nature (2023)
Masatoshi Sakurai, Kantaro Ishitsuka, Ryoji Ito, Adam C Wilkinson, Takaharu Kimura, Eiji Mizutani, Hidekazu Nishikii, Kazuhiro Sudo, Hans Jiro Becker, Hiroshi Takemoto, Tsubasa Sano, Keisuke Kataoka, Satoshi Takahashi, Yukio Nakamura, David G Kent, Atsushi Iwama, Shigeru Chiba, Shinichiro Okamoto, Hiromitsu Nakauchi, Satoshi Yamazaki
Chemically defined cytokine-free expansion of human haematopoietic stem cells. Nature 615 (7950) (2023)
Masatoshi Sakurai, Kantaro Ishitsuka, Ryoji Ito, Adam C Wilkinson, Takaharu Kimura, Eiji Mizutani, Hidekazu Nishikii, Kazuhiro Sudo, Hans Jiro Becker, Hiroshi Takemoto, Tsubasa Sano, Keisuke Kataoka, Satoshi Takahashi, Yukio Nakamura, David G Kent, Atsushi Iwama, Shigeru Chiba, Shinichiro Okamoto, Hiromitsu Nakauchi, Satoshi Yamazaki
Chemically defined cytokine-free expansion of human haematopoietic stem cells. Nature 615 (7950) (2023)
Maria Jassinskaja, Monika Gonka, David G Kent
Resolving the hematopoietic stem cell state by linking functional and molecular assays. Blood (2023)
Maria Jassinskaja, Monika Gonka, David G Kent
Resolving the hematopoietic stem cell state by linking functional and molecular assays. Blood (2023)
Oliver J Herd, Gulab Fatima Rani, James P Hewitson, Karen G Hogg, Andrew P Stone, Nichola Cooper, David G Kent, Paul G Genever, Ian S Hitchcock
Bone marrow remodeling supports hematopoiesis in response to immune thrombocytopenia progression in mice. Blood advances 5 (23) (2022)
Juan Li, Matthew J Williams, Hyun Jung Park, Hugo P Bastos, Xiaonan Wang, Daniel Prins, Nicola K Wilson, Carys Johnson, Kendig Sham, Michelle Wantoch, Sam Watcham, Sarah J Kinston, Dean C Pask, Tina L Hamilton, Rachel Sneade, Amie K Waller, Cedric Ghevaert, George S Vassiliou, Elisa Laurenti, David G Kent, Berthold Göttgens, Anthony R Green
STAT1 is essential for HSC function and maintains MHCIIhi stem cells that resist myeloablation and neoplastic expansion. Blood 140 (14) (2022)
Brianne A Kent, Constance Holman, Emmanuella Amoako, Alberto Antonietti, James M Azam, Hanne Ballhausen, Yaw Bediako, Anat M Belasen, Clarissa F D Carneiro, Yen-Chung Chen, Ewoud B Compeer, Chelsea A C Connor, Sophia Crüwell, Humberto J Debat, Emma Dorris, Hedyeh Ebrahimi, Jeffrey C Erlich, Florencia Fernández-Chiappe, Felix Fischer, Małgorzata Anna Gazda, Toivo Glatz, Peter Grabitz, Verena Heise, David G Kent, Hung Lo, Gary S McDowell, Devang Mehta, Wolf-Julian Neumann, Kleber Neves, Mark Patterson, Naomi C Penfold, Sophie Käthe Piper, Iratxe Puebla, Peter Kojo Quashie, Carolina Paz Quezada, Julia L Riley, Jessica Lee Rohmann, Shyam Saladi, Benjamin Schwessinger, Bob Siegerink, Paulina Stehlik, Alexandra Tzilivaki, Kate D L Umbers, Aalok Varma, Kaivalya Walavalkar, Charlotte M de Winde, Cecilia Zaza, Tracey L Weissberger
Recommendations for empowering early career researchers to improve research culture and practice. PLoS biology 20 (7) (2022)
Heather E Machado, Emily Mitchell, Nina F Øbro, Kirsten Kübler, Megan Davies, Daniel A Leongamornlert, Alyssa Cull, Francesco Maura, Mathijs A Sanders, Alex T J Cagan, Craig McDonald, Miriam Belmonte, Mairi S Shepherd, Felipe A Vieira Braga, Robert J Osborne, Krishnaa T A Mahbubani, Iñigo Martincorena, Elisa Laurenti, Anthony R Green, Gad A Getz, Paz Polak, Kourosh Saeb Parsy, Daniel James Hodson, David G Kent, Peter J Campbell
Diverse mutational landscapes in human lymphocytes. Nature 608 (7924) (2022)
Laure Talarmain, Matthew A Clarke, David Shorthouse, Lilia Cabrera-Cosme, David G Kent, Jasmin Fisher, Michael W J Hall
HOXA9 has the hallmarks of a biological switch with implications in blood cancers. Nature communications 13 (1) (2022)
Fiona M Bain, James L C Che, Maria Jassinskaja, David G Kent
Lessons from early life: understanding development to expand stem cells and treat cancers. Development (Cambridge, England) 149 (20) (2022)
James L C Che, Daniel Bode, Iwo Kucinski, Alyssa H Cull, Fiona Bain, Hans J Becker, Maria Jassinskaja, Melania Barile, Grace Boyd, Miriam Belmonte, Andy G X Zeng, Kyomi J Igarashi, Juan Rubio-Lara, Mairi S Shepherd, Anna Clay, John E Dick, Adam C Wilkinson, Hiromitsu Nakauchi, Satoshi Yamazaki, Berthold Göttgens, David G Kent
Identification and characterization of in vitro expanded hematopoietic stem cells. EMBO reports 23 (10) (2022)
Emily Mitchell, Michael Spencer Chapman, Nicholas O Williams, Kevin J Dawson, Nicole Mende, Emily F Calderbank, Hyunchul Jung, Thomas Mitchell, Tim H H Coorens, David H Spencer, Heather Machado, Henry Lee-Six, Megan Davies, Daniel Hayler, Margarete A Fabre, Krishnaa T A Mahbubani, Federico Abascal, Alex T J Cagan, George S Vassiliou, Joanna Baxter, Iñigo Martincorena, Michael R Stratton, David G Kent, Krishna Chatterjee, Kourosh Saeb Parsy, Anthony R Green, Jyoti Nangalia, Elisa Laurenti, Peter J Campbell
Clonal dynamics of haematopoiesis across the human lifespan. Nature 606 (7913) (2022)
Mairi S Shepherd, Juan Li, Nicola K Wilson, Caroline A Oedekoven, Jiangbing Li, Miriam Belmonte, Juergen Fink, Janine C M Prick, Dean C Pask, Tina L Hamilton, Dirk Loeffler, Anjana Rao, Timm Schroeder, Berthold Göttgens, Anthony R Green, David G Kent
Single-cell approaches identify the molecular network driving malignant hematopoietic stem cell self-renewal. Blood 132 (8) (2018)
Juan Li, David G Kent, Anna L Godfrey, Harriet Manning, Jyoti Nangalia, Athar Aziz, Edwin Chen, Kourosh Saeb-Parsy, Juergen Fink, Rachel Sneade, Tina L Hamilton, Dean C Pask, Yvonne Silber, Xiaodong Zhao, Cedric Ghevaert, Pentao Liu, Anthony R Green
JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease. Blood 123 (20) (2014)

David G Kent.css-eqlu8i{font-size:small;padding-left:4px;} (David Kent)

Publication Activity (10 Years)

Top Topics

Top Venues

David G Kent (David Kent)